Clinical trial
A Phase 2, Double-blind, Randomized Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain
NCT01351090 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Double-blind, Randomized Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain
- Lead sponsor
- American Regent, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- October 31, 2007
- Enrollment
- 127 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.